PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8834597-1	1996	Changes in the activity of GOT, GPT, AP and GGTP in blood of rats intoxicated by low doses of N-Nitrosodimethylamine (NDMA) are presented.	Dimethylnitrosamine	94-116	glutamic--pyruvic transaminase	Rattus norvegicus	32-35	
6719461-2	1984	This study demonstrates that these same treatments also potentiate the hepatotoxicity of NDMA as indicated by plasma glutamic pyruvate transaminase (GPT) levels and histologic data.	Dimethylnitrosamine	89-93	glutamic--pyruvic transaminase	Rattus norvegicus	117-147	
6719461-2	1984	This study demonstrates that these same treatments also potentiate the hepatotoxicity of NDMA as indicated by plasma glutamic pyruvate transaminase (GPT) levels and histologic data.	Dimethylnitrosamine	89-93	glutamic--pyruvic transaminase	Rattus norvegicus	149-152	
6719461-3	1984	Pretreatment with acetone or isopropanol (2.5 ml/kg) and 2 days of fasting caused a 2-fold potentiation of NDMA-induced plasma GPT elevation, whereas streptozotocin-induced diabetes caused a 4.6-fold potentiation.	Dimethylnitrosamine	107-111	glutamic--pyruvic transaminase	Rattus norvegicus	127-130	
7191620-2	1980	administration of dimethylnitrosamine (DMN) on 5 consecutive days to rats fed a nutritionally adequate liquid diet resulted 24 hours after the last injection of significant increases in glutamic dehydrogenase (GDH), glutamic oxylacetate transaminase (GOT), and glutamic pyruvate transaminase (GPT) activities in the serum, indicating a striking hepatotoxic effect of this compound.	Dimethylnitrosamine	18-37	glutamic--pyruvic transaminase	Rattus norvegicus	261-291	
7191620-2	1980	administration of dimethylnitrosamine (DMN) on 5 consecutive days to rats fed a nutritionally adequate liquid diet resulted 24 hours after the last injection of significant increases in glutamic dehydrogenase (GDH), glutamic oxylacetate transaminase (GOT), and glutamic pyruvate transaminase (GPT) activities in the serum, indicating a striking hepatotoxic effect of this compound.	Dimethylnitrosamine	18-37	glutamic--pyruvic transaminase	Rattus norvegicus	293-296	
7191620-2	1980	administration of dimethylnitrosamine (DMN) on 5 consecutive days to rats fed a nutritionally adequate liquid diet resulted 24 hours after the last injection of significant increases in glutamic dehydrogenase (GDH), glutamic oxylacetate transaminase (GOT), and glutamic pyruvate transaminase (GPT) activities in the serum, indicating a striking hepatotoxic effect of this compound.	Dimethylnitrosamine	39-42	glutamic--pyruvic transaminase	Rattus norvegicus	261-291	
7191620-2	1980	administration of dimethylnitrosamine (DMN) on 5 consecutive days to rats fed a nutritionally adequate liquid diet resulted 24 hours after the last injection of significant increases in glutamic dehydrogenase (GDH), glutamic oxylacetate transaminase (GOT), and glutamic pyruvate transaminase (GPT) activities in the serum, indicating a striking hepatotoxic effect of this compound.	Dimethylnitrosamine	39-42	glutamic--pyruvic transaminase	Rattus norvegicus	293-296	
24250714-6	2013	Compared with the normal control rats, rats treated with DMN for either 2 weeks or 4 weeks had significantly lower body weights, liver indexes and elevation of hydroxyproline, GOT, and GPT contents.	Dimethylnitrosamine	57-60	glutamic--pyruvic transaminase	Rattus norvegicus	185-188	
15744066-2	2005	After treated with DMN for 4 weeks, the levels of aminotrasferases (GOT, GPT) were significantly elevated in serum, and the levels of total protein (TP) and albumin were significantly decreased in serum and liver homogenates.	Dimethylnitrosamine	19-22	glutamic--pyruvic transaminase	Rattus norvegicus	73-76